SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending due to a significant European distribution partnership for its Anktiva cancer therapy, a critical FDA resubmission, and strong indications of major funding from Saudi Arabia. Investors are keenly watching for a potential short squeeze, fueled by enthusiasm for the drug's global market potential and ongoing discussions around US regulatory progress.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is actively trending as its 'move-to-earn' model sparks ongoing debate within the crypto community. Many holders express optimism for a future rebound and are accumulating tokens despite a currently low valuation, while others remain skeptical of its long-term viability.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending following a significant stock drop sparked by its Q4 earnings, which revealed a net loss and weak guidance, intensifying community debate over the 'Buy Now, Pay Later' model's sustainability and the company's valuation after its already steep post-IPO decline.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending after its NHS-Galleri cancer screening trial delivered mixed results, missing a primary endpoint but demonstrating promising early detection for several deadly cancers. The community is sharply divided, with some viewing the significant stock drop as an overreaction given the company's strong cash position and ongoing US FDA progress, while others see it as a justified response to the trial's outcome.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending following its robust earnings report which was subsequently overshadowed by conservative 2026 gold production guidance and higher anticipated costs. This has sparked a sharp debate among investors, with some seeing a compelling buying opportunity while others express concern about future profitability despite strong gold prices.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is actively discussed after pricing a public stock offering at $5.45 and securing a royalty funding agreement, prompting a polarized community debate between significant dilution concerns and the strategic cash infusion to advance its promising prostate cancer BLA and broader oncology pipeline. The capital raises, including validation from RTW Investments, are viewed by some as crucial for accelerating regulatory milestones, while others express disappointment over the timing and share issuance.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

The cryptocurrency $SATOSHI is trending as the community fervently champions its tokenization of Satoshi Nakamoto, viewing it as the ultimate, timeless narrative and foundational identity of the entire crypto industry. Supporters believe its limited supply and unparalleled significance position it as a monumental asset destined to eclipse other major tokens, representing a unique opportunity akin to being early on Bitcoin.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as its amended offer for Warner Bros. Discovery, including additional financial protections and a focus on regulatory certainty, has prompted WBD to reopen deal talks despite prior support for a rival bid. Community discussion centers on whether this will lead to PSKY acquiring WBD, given ongoing antitrust scrutiny on the competitor's proposal and the potential significant debt impact on PSKY.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is trending due to an S-1 filing for a Grayscale Trust and its deepening integration into the AI sector through NVIDIA's program, with the community highly engaged in discussions around its chain abstraction technology for seamless cross-chain interoperability and long-term potential.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is generating significant buzz following its recent earnings, which showed strong revenue growth, same-shop transaction increases, and store expansion including a new acquisition. Despite positive business updates and S&P MidCap 400 index inclusion, the stock experienced volatility, fueling a debate among investors weighing its high valuation against its impressive growth trajectory in the competitive coffee sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and agriculture. Its breakthrough biomanufacturing platform is engaged in discovering, developing, scaling, and commercializing RNA solutions at volume across multiple sectors in the agricultural and human health markets. The company is headquartered in Lexington, MA.

GRNA
GreenLight Biosciences Inc

Feed

News

Sentiment

Fundamentals

Info

Latest GRNA News

GRNAGreenLight Biosciences Inc